Document Detail


Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy.
MedLine Citation:
PMID:  7911417     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To define contemporary age- and sex-related mortality risks and patterns of medical practice in acute myocardial infarction (AMI). DESIGN: Retrospective comparison of demographic and clinical variables, including the use of proven effective AMI medical therapy, among AMI patients cohorts from 1987 to 1992. PATIENTS/SETTING: Of a total of 2,070 AMI patients, 629 were women and 1,441, men; 951 patients were managed in university hospitals, 641 in a regional hospital, and 478 in community hospitals. INTERVENTIONS: No direct study interventions; results of practice patterns and risk analyses of the earlier (1987-90) AMI cohorts, however, were published concurrently with the actual practices of the more recent (1991-92) cohorts and may have had some indirect effect on the recent practice patterns. RESULTS: Univariate analysis showed that mortality was higher (p < 0.0001) and use of thrombolysis, beta blockers, and acetylsalicylic acid was lower (p < 0.0001) in patients 70 years of age and older, compared with younger patients, and in women, compared with men. Multivariate analysis of the entire patient sample revealed age of 75 years or older (154 percent) and age 70 to 74 years (141 percent) to be associated with the highest relative risk of death in hospital. The increased relative risk associated with previous AMI was 45 percent. Acetylsalicylic acid use was associated with the greatest decrease in relative risk of death (-69 percent), followed by beta blockers (-36 percent) and thrombolysis (-31 percent). These patterns of relative risk were the same for men and women. CONCLUSIONS: Among contemporary AMI patients, advanced age and female sex are associated with relative under-utilization of proven effective medical therapy and increased risk of dying in the hospital. Although the contribution of age to AMI risk appears greater than that of gender, survival in any high risk group would likely be improved by increased use of proven medical therapy.
Authors:
R T Tsuyuki; K K Teo; R M Ikuta; K S Bay; P V Greenwood; T J Montague
Related Documents :
8049607 - Cholesterol and lipoprotein(a) as risk factors for coronary heart disease in elderly su...
8499817 - Coronary artery surgery: are women discriminated against?
16724967 - Impact of age on the outcomes of women following percutaneous coronary intervention in ...
17631037 - Hospital mortality in acute coronary syndrome: differences related to gender and use of...
20381517 - Prevalence of self-reported clinically diagnosed sleep apnea according to obesity statu...
12850997 - Testing proximal and distal protective processes in preterm high-risk children.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Chest     Volume:  105     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1994 Jun 
Date Detail:
Created Date:  1994-07-08     Completed Date:  1994-07-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1687-92     Citation Subset:  AIM; IM    
Affiliation:
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Age Factors
Aged
Aspirin / therapeutic use
Canada / epidemiology
Cohort Studies
Female
Hospital Mortality*
Humans
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction / drug therapy,  mortality*
Outcome and Process Assessment (Health Care) / statistics & numerical data*
Physician's Practice Patterns / statistics & numerical data*
Retrospective Studies
Risk Factors
Sex Factors
Thrombolytic Therapy
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Equivalence of litmus paper and intragastric pH probes for intragastric pH monitoring in the intensi...
Next Document:  Physician estimation of FEV1 in acute exacerbation of COPD.